They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

MMS, an award-winning, data-focused clinical research organization (CRO), announced today its acquisition of Exploristics, a leading biostatistics and data science company based in Belfast, Northern ...

Under the helm of Madhu G. Nadig, Flagright vows to combat financial crime with a holistic AML compliance platform.

Artificial Intelligence (AI) and deep learning have already transformed several aspects of small molecule drug design ... with Amazon Web Services, Inc. (AWS) and the Israel Biotech Fund (IBF ...

Rancher Government Solutions (RGS), the leader in Kubernetes management for government agencies, and Sequoia Holdings, LLC., a trusted expert in DevSecOps and secure workload migration, today ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Andy Jassy, president and CEO of Amazon, described the final quarter of 2024 as being one of “remarkable innovation” for AWS, following the roll-out of new artificial intelligence (AI ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...